Nektar Therapeutics (NKTR) Liabilities and Shareholders Equity (2010 - 2026)
Nektar Therapeutics (NKTR) reported Liabilities and Shareholders Equity of $1.1 billion for Q2 2026, up 427.7% from $207.53 million a year earlier and up 43.5% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Nektar Therapeutics posted Liabilities and Shareholders Equity of $280.41 million, down 7.7% from FY2024.
- Liabilities and Shareholders Equity has declined for seven consecutive years, with a five-year compound annual growth rate of -28.9% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $303.85 million in FY2024 (-23.7%), $398.03 million in FY2023 (-44.0%), $710.6 million in FY2022 (-36.4%) and $1.12 billion in FY2021 (-27.4%).
- The Q2 2026 figure ranks as the highest quarterly Liabilities and Shareholders Equity since Q4 2021.
- Year over year, Liabilities and Shareholders Equity gained in two of the last eight quarters, with growth averaging 60.9%.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q2 2026 (growth of 427.7%); the low point was Q1 2023 (a decline of 45.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $763.27 million (Q1 2026), $280.41 million (Q4 2025) and $301.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Nektar Therapeutics | 2.00 Bn | 232.24 Mn | - | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Bn |
| Mar 31, 2026 | 763.27 Mn |
| Dec 31, 2025 | 280.41 Mn |
| Sep 30, 2025 | 301.35 Mn |
| Jun 30, 2025 | 207.53 Mn |
| Mar 31, 2025 | 256.24 Mn |
| Dec 31, 2024 | 303.85 Mn |
| Sep 30, 2024 | 307.97 Mn |
| Jun 30, 2024 | 343.33 Mn |
| Mar 31, 2024 | 396.01 Mn |
| Dec 31, 2023 | 398.03 Mn |
| Sep 30, 2023 | 442.24 Mn |
| Jun 30, 2023 | 494.28 Mn |
| Mar 31, 2023 | 561.74 Mn |
| Dec 31, 2022 | 710.60 Mn |
| Sep 30, 2022 | 781.01 Mn |
| Jun 30, 2022 | 861.99 Mn |
| Mar 31, 2022 | 1.02 Bn |
| Dec 31, 2021 | 1.12 Bn |
| Sep 30, 2021 | 1.28 Bn |
API Access
Nektar Therapeutics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();